Co-Pay Relief Program Announces Assistance for Three New Disease Areas
Program eases cost burden through launch of uterine cancers, skin cancer and rheumatoid arthritis funds
PAF’s Co-Pay Relief (CPR) program is pleased to announce that assistance will now be available to patients with uterine cancers, skin cancer and rheumatoid arthritisthrough three newly launched disease funds. These new funds further expand the program’s existing service which can provide direct financial assistance to qualified patients with co-payments, co-insurance or cost-sharing associated with pharmaceutical treatments and/or prescription medications through funds dedicated to specific disease states.
Specific eligibility criteria for each of the new funds can be found at https://www.copays.org/diseases. The Co-Pay Relief Program may help with all therapeutic and supportive medications, including generic or bioequivalent products prescribed to treat and/or manage the patient’s disease or condition and theprogram provides assistance to patients on a first-come, first-serve basis and processes applicants in the order in which their completed applications are received.
For personal assistance with the application process please contact us toll free at 866-512-3861 or visit our application portals at https://www.copays.org/gateway, with access available for patients, providers and pharmacies.